Have a feature idea you'd love to see implemented?
Let us know!
PHGE BiomX Inc
Price (delayed)
$0.4918
Market cap
$8.94M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.01
Enterprise value
-$5.96M
BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria
Highlights
BiomX's debt has decreased by 40% YoY
The equity rose by 38% QoQ
The quick ratio has surged by 51% year-on-year but it has declined by 38% since the previous quarter
PHGE's EPS has dropped by 167% year-on-year and by 67% since the previous quarter
BiomX's net income has shrunk by 91% QoQ
Key stats
What are the main financial stats of PHGE
Market
Valuations
Earnings
Shares outstanding
18.18M
Market cap
$8.94M
Enterprise value
-$5.96M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.23
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$35.58M
EBITDA
-$34.48M
Free cash flow
-$36.89M
Per share
Balance sheet
Liquidity
EPS
-$4.01
Free cash flow per share
-$2.25
Book value per share
$2.12
Revenue per share
$0
TBVPS
$3.66
Total assets
$59.98M
Total liabilities
$22.08M
Debt
$9.75M
Equity
$37.9M
Working capital
$19.37M
Debt to equity
0.26
Current ratio
3.17
Quick ratio
2.76
Net debt/EBITDA
0.43
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-62.8%
Return on equity
-251%
Return on invested capital
-114.2%
Return on capital employed
-69.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PHGE stock price
How has the BiomX stock price performed over time
Intraday
-3.38%
1 week
-34.43%
1 month
-48.89%
1 year
-87.71%
YTD
-82.44%
QTD
-51.78%
Financial performance
How have BiomX's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.11M
Net income
-$36.93M
Gross margin
N/A
Net margin
N/A
BiomX's net income has shrunk by 91% QoQ
PHGE's operating income is down by 29% YoY and by 12% QoQ
Growth
What is BiomX's growth rate over time
Valuation
What is BiomX stock price valuation
P/E
N/A
P/B
0.23
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
PHGE's EPS has dropped by 167% year-on-year and by 67% since the previous quarter
The stock's P/B is 86% below its 5-year quarterly average of 1.6
The equity rose by 38% QoQ
Efficiency
How efficient is BiomX business performance
The ROA has plunged by 69% from the previous quarter
PHGE's return on invested capital has dropped by 56% since the previous quarter
The ROE is up by 6% since the previous quarter
Dividends
What is PHGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PHGE.
Financial health
How did BiomX financials performed over time
The total assets is 172% greater than the total liabilities
The total assets has surged by 81% year-on-year but it has declined by 13% since the previous quarter
BiomX's current ratio has surged by 60% YoY but it has decreased by 34% QoQ
BiomX's debt is 74% less than its equity
The company's debt to equity has shrunk by 87% YoY and by 28% QoQ
BiomX's debt has decreased by 40% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.